The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow ...